Barbara Lysy
Impact in
-
- Peptidase Inhibition and Analysis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Protein Degradation and Inhibitors 3
- Cancer-related gene regulation 2
- Ubiquitin and proteasome pathways 2
- Epigenetics and DNA Methylation 1
-
- Prostate Cancer Treatment and Research 5
- Co-authors
- Sarki A. Abdulkadir (7 shared papers)Kenji Unno (6 shared papers)Rajita Vatapalli (6 shared papers)Young A. Yoo (5 shared papers)Yara Rodríguez (5 shared papers)Vinay Sagar (5 shared papers)Zachary R. Chalmers (4 shared papers)Huiying Han (4 shared papers)
- Journals
- Nature Communications (2 papers)Cancer Research (2 papers)JNCI Journal of the National Cancer Institute (1 paper)Cell Death and Disease (1 paper)Cancer Cell (1 paper)
- Partner nations
- United StatesChina
In The Last Decade
Barbara Lysy
7 papers receiving 566 citations
Barbara Lysy's Hit Papers
Peers
Comparison fields: 5 of 64
- Oncology 192
- Cancer Research 96
- Molecular Biology 380
- Pulmonary and Respiratory Medicine 150
- Immunology 79
Countries citing papers authored by Barbara Lysy
This map shows the geographic impact of Barbara Lysy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Lysy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Lysy more than expected).
Fields of papers citing papers by Barbara Lysy
This network shows the impact of papers produced by Barbara Lysy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Lysy. The network helps show where Barbara Lysy may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Lysy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Small-Molecule MYC Inhibitors Suppress Tumor Growth and Enhance Immunotherapy Hit paper breakdown → | 2019 | 302 |
| 2 | 2020 | 77 | |
| 3 | 2016 | 49 | |
| 4 | 2019 | 44 | |
| 5 | 2021 | 41 | |
| 6 | 2018 | 31 | |
| 7 | 2022 | 24 |
About Barbara Lysy
Barbara Lysy is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Oncology, Cell Biology and Cellular and Molecular Neuroscience, having authored 7 papers that have together received 568 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (5 papers), Protein Degradation and Inhibitors (3 papers), Cancer-related gene regulation (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Ubiquitin and proteasome pathways (2 papers), Epigenetics and DNA Methylation (1 paper), Neuroendocrine Tumor Research Advances (1 paper) and CAR-T cell therapy research (1 paper). The work is most often cited by research in Oncology (192 citations), Cancer Research (96 citations), Molecular Biology (380 citations), Pulmonary and Respiratory Medicine (150 citations) and Immunology (79 citations). Barbara Lysy has collaborated with scholars based in United States and China. Frequent co-authors include Sarki A. Abdulkadir, Kenji Unno, Rajita Vatapalli, Young A. Yoo, Yara Rodríguez, Vinay Sagar, Zachary R. Chalmers, Huiying Han, Hanlin Mok and Jonathan F. Anker. Their work appears in journals such as Nature Communications, Cancer Research, JNCI Journal of the National Cancer Institute, Cell Death and Disease and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.